AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
172.48
+2.84 (1.67%)
At close: Jul 28, 2026, 4:00 PM EDT
171.00
-1.48 (-0.86%)
After-hours: Jul 28, 2026, 7:54 PM EDT

AstraZeneca Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
12,58612,4028,6916,8992,501-265
Depreciation & Amortization
6,3555,7336,6885,3875,4806,530
Other Adjustments
-90422125125-307-580
Change in Receivables
--1,728-1,624-1,425-1,349-961
Changes in Inventories
--755-131-6693,9411,577
Changes in Accounts Payable
-1,3468622,3941,1651,405
Changes in Income Taxes Payable
-3,347-2,845-2,750-2,366-1,623-1,743
Changes in Other Operating Activities
-603-----
Operating Cash Flow
13,70014,57511,86110,3459,8085,963
Operating Cash Flow Growth
2.32%22.88%14.65%5.47%64.48%24.25%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3,032-2,810-1,924-1,361-1,091-1,091
Sale of Property, Plant & Equipment
15135513228213
Purchases of Intangible Assets
-4,624-3,095-2,662-2,417-1,480-1,109
Proceeds from Sale of Intangible Assets
206136123291447587
Purchases of Investments
-83-239-254-216-71-276
Proceeds from Sale of Investments
--913242785
Cash Acquisitions
-825-1,230-3,779-1,015-820-9,906
Other Investing Activities
255417370490-269-61
Investing Cash Flow
-8,151-6,808-7,980-4,064-2,960-11,058

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
945364-3116174-552
Net Short-Term Debt Issued (Repaid)
945364-3116174-552
Long-Term Debt Issued
2,003156,4923,816-25,858
Long-Term Debt Repaid
-4,466-2,029-4,652-4,942-1,271-9,518
Net Long-Term Debt Issued (Repaid)
-2,463-2,0141,840-1,126-1,27116,340
Issuance of Common Stock
444038332929
Repurchase of Common Stock
-690-521-81---
Net Common Stock Issued (Repurchased)
-646-481-43332929
Common Dividends Paid
-4,902-4,971-4,629-4,481-4,364-3,856
Other Financing Activities
-614-442-1,133-1,154-1,418-687
Financing Cash Flow
-7,680-7,544-3,996-6,567-6,8233,649

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1746-93-60-80-62
Net Cash Flow
-2,148269-208-346-55-1,508

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
10,66811,7659,9378,9848,7174,872
Free Cash Flow Growth
-4.54%18.40%10.61%3.06%78.92%26.94%
FCF Margin
17.38%20.03%18.38%19.61%19.65%13.02%
Free Cash Flow Per Share
6.837.536.365.755.593.41
Levered Free Cash Flow
8,3019,24411,5898,3759,96322,578
Unlevered Free Cash Flow
10,97612,00810,84910,46412,8196,220
SEC Filings: 10-K · 10-Q